论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Zhou Z, Zhu Y, Wang J, Zhu H
Received 27 August 2016
Accepted for publication 27 October 2016
Published 28 December 2016 Volume 2017:13 Pages 101—107
DOI https://doi.org/10.2147/NDT.S120843
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 4
Editor who approved publication: Professor Wai Kwong Tang
Objective: To investigate whether risperidone improves social cognitive impairments
and executive dysfunction in people with schizophrenia.
Methods: Fifty-six patients who met the Diagnostic and Statistical Manual of Mental
Disorders , Fifth Edition, diagnostic criteria for schizophrenia
were allocated to a risperidone treatment group (RTG, n=28) and a typical
antipsychotic treatment group (TATG, n=28). Twenty-eight healthy volunteers
were recruited as the normal control group (NCG). The Positive and Negative
Syndrome Scale, Interpersonal Perception Task-15 (IPT-15), and Wisconsin Card
Sorting Test (WCST) were rated at baseline and after 4 and 12 weeks of
treatment with risperidone or typical antipsychotics.
Results: Risperidone and typical antipsychotics decreased Positive and Negative
Syndrome Scale scores for total psychopathology and positive and negative
symptoms. At baseline, in the IPT-15, total scores and five factor scores, as
well as the number of categories completed and the percentage of conceptual
level responses, were significantly lower in the RTG and TATG than in the NCG,
whereas total response errors, perseverative errors, and failure to maintain
set were significantly higher in the patient groups than in the NCG. Repeated
measures analysis of variance revealed a significant main effect of time period
(baseline, 4 weeks, and 12 weeks) for IPT-15 scores and WCST performances, and
significant interactions for time period × group (RTG and TATG). Multivariate
analysis of variance showed no significant differences between the RTG and TATG
on IPT-15 scores at 4 weeks, but there were significant differences between
these two groups at 12 weeks. Significant differences were also found between
the RTG and TATG on WCST performances at 4 and 12 weeks.
Conclusion: Individuals with schizophrenia have impairments in social cognitive and
executive function, which might be improved by risperidone.
Keywords: schizophrenia, executive function, social cognition, Interpersonal
Perception Task-15, Wisconsin Card Sorting Test